Champions Oncology Statistics
Total Valuation
CSBR has a market cap or net worth of $91.62 million. The enterprise value is $88.16 million.
Important Dates
The last earnings date was Wednesday, July 23, 2025, after market close.
| Earnings Date | Jul 23, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSBR has 13.78 million shares outstanding. The number of shares has increased by 5.31% in one year.
| Current Share Class | 13.78M |
| Shares Outstanding | 13.78M |
| Shares Change (YoY) | +5.31% |
| Shares Change (QoQ) | -4.26% |
| Owned by Insiders (%) | 25.91% |
| Owned by Institutions (%) | 13.02% |
| Float | 5.12M |
Valuation Ratios
The trailing PE ratio is 20.15 and the forward PE ratio is 30.23.
| PE Ratio | 20.15 |
| Forward PE | 30.23 |
| PS Ratio | 1.60 |
| Forward PS | 1.50 |
| PB Ratio | 24.29 |
| P/TBV Ratio | 26.66 |
| P/FCF Ratio | 13.09 |
| P/OCF Ratio | 12.40 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 13.59, with an EV/FCF ratio of 12.60.
| EV / Earnings | 18.75 |
| EV / Sales | 1.55 |
| EV / EBITDA | 13.59 |
| EV / EBIT | 18.19 |
| EV / FCF | 12.60 |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of 1.68.
| Current Ratio | 0.94 |
| Quick Ratio | 0.88 |
| Debt / Equity | 1.68 |
| Debt / EBITDA | 0.76 |
| Debt / FCF | 0.90 |
| Interest Coverage | 179.48 |
Financial Efficiency
Return on equity (ROE) is 503.05% and return on invested capital (ROIC) is 38.77%.
| Return on Equity (ROE) | 503.05% |
| Return on Assets (ROA) | 10.36% |
| Return on Invested Capital (ROIC) | 38.77% |
| Return on Capital Employed (ROCE) | 57.07% |
| Revenue Per Employee | $271,162 |
| Profits Per Employee | $22,386 |
| Employee Count | 213 |
| Asset Turnover | 1.95 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -75,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +35.71% in the last 52 weeks. The beta is 0.44, so CSBR's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | +35.71% |
| 50-Day Moving Average | 7.20 |
| 200-Day Moving Average | 7.45 |
| Relative Strength Index (RSI) | 37.35 |
| Average Volume (20 Days) | 33,286 |
Short Selling Information
The latest short interest is 109,221, so 0.79% of the outstanding shares have been sold short.
| Short Interest | 109,221 |
| Short Previous Month | 95,869 |
| Short % of Shares Out | 0.79% |
| Short % of Float | 2.13% |
| Short Ratio (days to cover) | 2.85 |
Income Statement
In the last 12 months, CSBR had revenue of $56.94 million and earned $4.70 million in profits. Earnings per share was $0.33.
| Revenue | 56.94M |
| Gross Profit | 28.56M |
| Operating Income | 4.85M |
| Pretax Income | -7.31M |
| Net Income | 4.70M |
| EBITDA | 6.49M |
| EBIT | 4.85M |
| Earnings Per Share (EPS) | $0.33 |
Full Income StatementBalance Sheet
The company has $9.79 million in cash and $6.33 million in debt, giving a net cash position of $3.46 million or $0.25 per share.
| Cash & Cash Equivalents | 9.79M |
| Total Debt | 6.33M |
| Net Cash | 3.46M |
| Net Cash Per Share | $0.25 |
| Equity (Book Value) | 3.77M |
| Book Value Per Share | 0.27 |
| Working Capital | -1.48M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $7.39 million and capital expenditures -$389,000, giving a free cash flow of $7.00 million.
| Operating Cash Flow | 7.39M |
| Capital Expenditures | -389,000 |
| Free Cash Flow | 7.00M |
| FCF Per Share | $0.51 |
Full Cash Flow StatementMargins
Gross margin is 50.15%, with operating and profit margins of 8.51% and 8.26%.
| Gross Margin | 50.15% |
| Operating Margin | 8.51% |
| Pretax Margin | 8.12% |
| Profit Margin | 8.26% |
| EBITDA Margin | 11.39% |
| EBIT Margin | 8.51% |
| FCF Margin | 12.29% |
Dividends & Yields
CSBR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.31% |
| Shareholder Yield | -5.31% |
| Earnings Yield | 5.13% |
| FCF Yield | 7.64% |
Analyst Forecast
The average price target for CSBR is $12.00, which is 80.45% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 80.45% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 18.59% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on August 12, 2015. It was a reverse split with a ratio of 0.0833333:1.
| Last Split Date | Aug 12, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.0833333:1 |
Scores
CSBR has an Altman Z-Score of 0.58 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.58 |
| Piotroski F-Score | 7 |
